Ana Mónica Machado

Mrs. Ana Mónica Machado

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
AMAna Mónica Machado
Ana Mónica Machado
Fernanda LeiteFernanda Leite
Fernanda Leite
MPM. Graça Pereira
M. Graça Pereira
Background: Atrial fibrillation (AF) is the most common arrhythmia globally, associated with serious complications such as stroke and heart failure, as well as significant impacts on patients’ quality of life. Objectives: This theoretical article explores the role of integrated care in the management of AF, highlighting the need for a multidisciplinary approach that goes beyond rhythm and heart rate control. Methods: Through a review of the literature, this article explores the prevalence of AF, the challenges of diagnosis, the socioeconomic and psychological impact, as well as the benefits of integrating medical, psychological, and social interventions, drawing on insights from studies about integrative care in AF. Results: The findings highlight the challenges of managing AF, including its high prevalence, complex diagnosis, and significant socioeconomic and psychological impacts on patients. Integrated care models, combining medical, psychological, and social interventions, improve treatment adherence, reduce complications like stroke and heart failure, and enhance patient quality of life. Conclusions: Integrated care models hold significant promise in improving outcomes in AF patients through structured, multidisciplinary approaches. Evidence supports reductions in cardiovascular events, hospitalizations, and mortality when adhering to clinical guidelines, emphasizing patient education, and implementing individualized care strategies. Despite challenges, like regional disparities and suboptimal implementation, the integration of multidisciplinary teams and emerging technologies offers a way to enhance care delivery and accessibility. Future efforts should focus on personalizing care, promoting professional collaboration, and taking advantage of technological advances to optimize AF management and promote sustainable health systems.

12 October 2022 in Psych Journal
Verified
Journal Article
Closed access
AMAna Mónica Machado
Ana Mónica Machado
Margarida VilaçaMargarida Vilaça
Margarida Vilaça
APAna Luísa Patrão
Ana Luísa Patrão
MPM. Graça Pereira
M. Graça Pereira

15 May 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
MPM. Graça Pereira
M. Graça Pereira
AMAna Mónica Machado
Ana Mónica Machado
Margarida VilaçaMargarida Vilaça
Margarida Vilaça
Susana FariaSusana Faria
Susana Faria
IMIsabela Peres Monteiro
Isabela Peres Monteiro
Martim SantosMartim Santos
Martim Santos
Background: Somatic symptoms of stress are a major concern among the general population, given their severity and overall burden. Objectives: This pilot randomized controlled study (RCT) aimed to assess the effectiveness of frequency-specific microcurrent (FSM) therapy alone (experimental group 1 [EG1]) and combined with a relaxation intervention (experimental group 2 [EG2]), compared to a relaxation intervention alone (active control group [ACG]) and combined with placebo (passive control group [PCG]), to determine the need for a future definitive RCT. Methods: Participants with clinically significant levels of stress were recruited and assessed at three moments (i.e., baseline assessment [T0], at the end of six sessions [T1], and at the end of 12 sessions [T2]) on somatic symptoms and satisfaction with life (primary outcomes), perceived stress, emotional distress, emotional states, and emotion regulation (secondary outcomes). A total of 85 participants completed T0, of whom 58 were randomized into four groups. Results: Using linear mixed models, differences between groups revealed that the participants receiving FSM therapy reported fewer somatic symptoms and negative emotions than those who received relaxation, at T1. Within-group analysis showed that somatic symptoms and satisfaction with life significantly improved after six or twelve sessions of FSM therapy as well as after relaxation. There were also significant improvements in perceived stress, emotional distress, emotion regulation, and emotional states (negative emotions, self-efficacy, and serenity), after six and/or 12 sessions of FSM therapy or relaxation. Conclusions: The results suggest that FSM may be a promising treatment for addressing somatic complaints and negative emotional states, supporting the implementation of a definitive RCT.


27 February 2026 in Scandinavian Journal of Caring Sciences
Verified
Journal Article
Open access
AMAna Mónica Machado
Ana Mónica Machado
AFAna Ferraz
Ana Ferraz
Fernanda LeiteFernanda Leite
Fernanda Leite
MPM. Graça Pereira
M. Graça Pereira
Background: Atrial fibrillation is a common cardiac arrhythmia that significantly impacts patients' daily lives. While clinical management is well established, and despite growing interest in patient‐centred care, the perception and emotional response of patients with AF remain less explored. Objective: This study aimed to explore the experiences and perceived needs of patients with atrial fibrillation. Methods: A qualitative descriptive design was employed. Twenty adult patients diagnosed with AF and no cognitive impairment were recruited from a public hospital in northern Portugal. Semi‐structured interviews were conducted, audio‐recorded, transcribed verbatim and analysed using thematic content analysis supported by NVivo software. Themes were developed inductively and refined through iterative coding and discussion. Results: Five main themes were identified: (1) Dealing with a New Normal; (2) Embracing the Illness Journey; (3) Walking the Illness Journey; (4) Unmet Healthcare Needs, and (5) Improving Supportive Services. Conclusion: Patients with atrial fibrillation face challenges that extend beyond symptom management. Findings underscore the importance of integrated, theory‐informed, patient‐centred approaches to support individuals living with atrial fibrillation across diverse contexts.

20 February 2025 in Neurological Sciences
Verified
Journal Article
Open access
PDF file
AMAna Mónica Machado
Ana Mónica Machado
AFAna Ferraz
Ana Ferraz
MPM. Graça Pereira
M. Graça Pereira
Fernanda LeiteFernanda Leite
Fernanda Leite
Atrial fibrillation (AF) and cognitive decline represent significant health challenges with increasing prevalence and significant socioeconomic implications. Emerging evidence suggests a potential link between AF and cognitive decline, including dementia and Alzheimer’s disease, although the underlying mechanisms remain incompletely understood. Inflammation has emerged as a key mediator in cardiovascular and neurological diseases, encouraging an investigation into its role in the atrial fibrillation-cognition association. A systematic search of PubMed, Web of Science, and PsycInfo was conducted to identify relevant studies investigating possible inflammatory mechanisms bridging AF and cognitive decline. Studies were assessed for quality and relevance, and data were synthesized using a narrative approach. Five papers were included, with only two longitudinal studies. Inflammatory biomarkers emerged as significant factors associated with both AF and cognitive decline. Three studies revealed a correlation between high-sensitivity CRP (HS-CRP) levels and cognitive decline in patients with AF, AF patients with cerebral infarction, and elderly individuals with AF. However, conflicting results were observed, as one study did not identify any associations between cognitive decline and HS-CRP levels. The scientific literature on this topic is scarce, and the results of existing studies often lack consistency in their findings, highlighting the need for further research to better understand and prevent this significant health burden in patients with AF. So, the results of this study are expected to inform future research directions and cognitive decline risk stratification, guiding the development of targeted interventions aimed at preserving cognitive function and improving outcomes in patients with AF.